Home » Topics » Regulatory » Patents

Patents
RSS

Santen reveals neutral endopeptidase inhibitors

Aug. 23, 1996

Adenosine reuptake inhibitors from Kyowa Hakko

Aug. 23, 1996

Thiazolidinone compounds as antianginal agents from Sankyo

Aug. 23, 1996

Roche reveals EGF-R tyrosine kinase inhibitors

Aug. 23, 1996

Phospholipase A2 inhibitors from SmithKline Beecham

Aug. 23, 1996

More endothelin converting enzyme inhibitors from Warner-Lambert

Aug. 23, 1996

Ciba-Geigy claims endothelin converting enzyme inhibitors

Aug. 23, 1996

Roche discloses ETA antagonists for circulatory disorders

Aug. 23, 1996

Endothelin ETA inhibitors described by Roche

Aug. 23, 1996

Further nitric oxide synthase inhibitors from Chugai

Aug. 23, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.